Related references
Note: Only part of the references are listed.Estimating survival rates after ovarian cancer among women tested for BRCA1 and BRCA2 mutations
S. A. Narod et al.
CLINICAL GENETICS (2013)
Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
D. J. Park et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Cancer predisposing BARD1 mutations in breast-ovarian cancer families
Magdalena Ratajska et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Assessing the RNA effect of 26 DNA variants in the BRCA1 and BRCA2 genes
Mireia Menendez et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study
Florentia Fostira et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families
D. J. Osher et al.
BRITISH JOURNAL OF CANCER (2012)
Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families
Irene Catucci et al.
FAMILIAL CANCER (2012)
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance
Irma Kluijt et al.
FAMILIAL CANCER (2012)
Hereditary ovarian cancer: Beyond the usual suspects
Kathryn P. Pennington et al.
GYNECOLOGIC ONCOLOGY (2012)
Loss of function germline mutations in RAD51D in women with ovarian carcinoma
Anneka Wickramanyake et al.
GYNECOLOGIC ONCOLOGY (2012)
Response to DNA damage of CHEK2 missense mutations in familial breast cancer
Wendy Roeb et al.
HUMAN MOLECULAR GENETICS (2012)
Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families
Ana Osorio et al.
HUMAN MOLECULAR GENETICS (2012)
Rare germline mutations in PALB2 and breast cancer risk: A population-based study
Marc Tischkowitz et al.
HUMAN MUTATION (2012)
Rare variants in XRCC2 as breast cancer susceptibility alleles
Florentine S. Hilbers et al.
JOURNAL OF MEDICAL GENETICS (2012)
A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer
Liisa M. Pelttari et al.
JOURNAL OF MEDICAL GENETICS (2012)
Translational advances regarding hereditary breast cancer syndromes
M. Gage et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Silvia Casadei et al.
CANCER RESEARCH (2011)
RAD51C is a susceptibility gene for ovarian cancer
Liisa M. Pelttari et al.
HUMAN MOLECULAR GENETICS (2011)
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
Muriel A. Adank et al.
JOURNAL OF MEDICAL GENETICS (2011)
A role for XRCC2 gene polymorphisms in breast cancer risk and survival
Wei-Yu Lin et al.
JOURNAL OF MEDICAL GENETICS (2011)
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
Xiaohong R. Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
High Cancer Risk in Peutz-Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
M. G. F. van Lier et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Regulation of Homologous Recombination in Eukaryotes
Wolf-Dietrich Heyer et al.
ANNUAL REVIEW OF GENETICS, VOL 44 (2010)
Effect of BRCA2 sequence variants predicted to disrupt exonic splice enhancers on BRCA2 transcripts
Phillip J. Whiley et al.
BMC MEDICAL GENETICS (2010)
A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
Agnieszka Dansonka-Mieszkowska et al.
BMC MEDICAL GENETICS (2010)
PALB2 mutations in European familial pancreatic cancer families
E. P. Slater et al.
CLINICAL GENETICS (2010)
The importance of XRCC2 in RAD51-related DNA damage repair
Cathryn E. Tambini et al.
DNA REPAIR (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits
C. R. M. Lammens et al.
FAMILIAL CANCER (2010)
Peutz-Jeghers syndrome: a systematic review and recommendations for management
A. D. Beggs et al.
GUT (2010)
Mutation of the RAD51C gene in a Fanconi anemia-like disorder
Fiona Vaz et al.
NATURE GENETICS (2010)
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study
Roger L. Milne et al.
BREAST CANCER RESEARCH (2010)
Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer
Sylvie Desjardins et al.
BMC CANCER (2009)
Taking the time to make important decisions: The checkpoint effector kinases Chk1 and Chk2 and the DNA damage response
Travis H. Stracker et al.
DNA REPAIR (2009)
Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer
P. Langer et al.
GUT (2009)
Beyond Li Fraumeni Syndrome: Clinical Characteristics of Families With p53 Germline Mutations
Kelly D. Gonzalez et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)
Gilles Thomas et al.
NATURE GENETICS (2009)
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Wei Zheng et al.
NATURE GENETICS (2009)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2
Shahana Ahmed et al.
NATURE GENETICS (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Current Guidelines and Best Practice Evidence for Intensified/Enhanced Breast Cancer Screening in Women with BRCA Mutations
Cathleen M. Waters et al.
JNP-Journal for Nurse Practitioners (2009)
Effect of CHEK2 missense variant I157T on the risk of breast cancer in carriers of other CHEK2 or BRCA1 mutations
C. Cybulski et al.
JOURNAL OF MEDICAL GENETICS (2009)
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study
L. Mellemkjaer et al.
BRITISH JOURNAL OF CANCER (2008)
CHEK2* 1100delC genotyping for clinical assessment of breast cancer risk:: Meta-analyses of 26,000 patient cases and 27,000 controls
Maren Weischer et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genetic counseling and testing for common hereditary breast cancer syndromes - A paper from the 2007 William Beaumont Hospital symposium on molecular pathology
Dawn C. Allain
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene
Jirina Bartkova et al.
MOLECULAR ONCOLOGY (2008)
Nijmegen BREAKAGE SYNDROME mutations and risk of breast cancer
Natalia Bogdanova et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Greek BRCA1 and BRCA2 mutation spectrum:: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Irene Konstantopoulou et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Cancer risk of heterozygotes with the NBN founder mutation
Eva Seemanov et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D. Fackenthal et al.
NATURE REVIEWS CANCER (2007)
Advances in counselling and surveillance patients at risk for pancreatic cancer
Randall E. Brand et al.
GUT (2007)
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer
David J. Hunter et al.
NATURE GENETICS (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer
Pardeep Kaurah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response
Bin Wang et al.
SCIENCE (2007)
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox et al.
NATURE GENETICS (2007)
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland
Cezary Cybulski et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Novel genomic rearrangements in the BRCA1 gene detected in greek breast/ovarian cancer patients
Sophia Armaou et al.
EUROPEAN JOURNAL OF CANCER (2007)
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles
Sheila Seal et al.
NATURE GENETICS (2006)
ATM and breast cancer susceptibility
M. Ahmed et al.
ONCOGENE (2006)
The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability
K. Gudmundsdottir et al.
ONCOGENE (2006)
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Katri Heikkinen et al.
CARCINOGENESIS (2006)
Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study
Marcia Irene Canto et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome
Nicholas Hearle et al.
CLINICAL CANCER RESEARCH (2006)
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
T Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Characterization of BRCA1 and BRCA2 mutations in a large United States sample
SN Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis
William D. Foulkes
FAMILIAL CANCER (2006)
Cancer risks and mortality in heterozygous ATM mutation carriers
D Thompson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study
S Nseir et al.
CRITICAL CARE (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Hereditary cancer predisposition syndromes
JE Garber et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Ataxia-telangiectasia, an evolving phenotype
HH Chun et al.
DNA REPAIR (2004)
PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways
RT Abraham
DNA REPAIR (2004)
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria
AR Brooks-Wilson et al.
JOURNAL OF MEDICAL GENETICS (2004)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Relative frequency and morphology of cancers in STK11 mutation carriers
W Lim et al.
GASTROENTEROLOGY (2004)
The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility:: from the laboratory to clinical practice
F Graziano et al.
ANNALS OF ONCOLOGY (2003)
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells
G Suriano et al.
HUMAN MOLECULAR GENETICS (2003)
ESEfinder: a web resource to identify exonic splicing enhancers
L Cartegni et al.
NUCLEIC ACIDS RESEARCH (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
A Antoniou et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Prediction of pathogenic mutations in patients with early-onset breast cancer by family history
F Lalloo et al.
LANCET (2003)
BRCA2 T2722R is a deleterious allele that causes exon skipping
JD Fackenthal et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Listening to silence and understanding nonsense: Exonic mutations that affect splicing
L Cartegni et al.
NATURE REVIEWS GENETICS (2002)
An Exon splice enhancer mutation causes autosomal dominant GH deficiency
CT Moseley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Germline mutations of the BRICA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations
C Ghimenti et al.
GENES CHROMOSOMES & CANCER (2002)
Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families
PDP Pharoah et al.
GASTROENTEROLOGY (2001)
Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2 -: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial
MC King et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer
PL Welcsh et al.
HUMAN MOLECULAR GENETICS (2001)
Very high risk of cancer in familial Peutz-Jeghers syndrome
FM Giardiello et al.
GASTROENTEROLOGY (2000)
Evidence for simultaneous protein interactions between human Rad51 paralogs
D Schild et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases
BJ Blencowe
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Sorting out the complexity of SR protein functions
BR Graveley
RNA (2000)
Share Paper
